GlassScriptPhysician profile
Cinderella C Radu
NPI 1952547440
$3,863.40
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $559 · 2021: $2,297 · 2022: $333 · 2023: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,683.24 | 2019-2023 | |
| Pfizer INC. | $588.46 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $283.30 | 2019-2021 | |
| Amgen INC. | $185.20 | 2021 | |
| Alexion Pharmaceuticals, INC. | $143.73 | 2021 | |
| Puma Biotechnology, INC. | $126.74 | 2019-2021 | |
| Genzyme Corporation | $114.70 | 2019-2021 | |
| Dova Pharmaceuticals | $73.10 | 2019-2021 | |
| Beigene USA, INC. | $71.98 | 2020-2021 | |
| Celgene Corporation | $63.34 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $53.60 | 2021 | |
| Taiho Oncology, INC. | $46.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.75 | 2019 | |
| Array Biopharma INC | $42.98 | 2020-2021 | |
| Myovant Sciences INC. | $34.19 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $32.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.74 | 2019-2020 | |
| Emd Serono, INC. | $26.68 | 2021 | |
| Lilly USA, LLC | $24.70 | 2021 | |
| Incyte Corporation | $24.08 | 2021 | |
| Janssen Biotech, INC. | $23.93 | 2020 | |
| Gilead Sciences, INC. | $23.89 | 2021 | |
| Global Blood Therapeutics, INC. | $19.69 | 2021 | |
| Advanced Accelerator Applications | $18.22 | 2020 | |
| Merck Sharp & Dohme LLC | $16.45 | 2020 | |
| Secura Bio, INC. | $15.83 | 2019 | |
| Epizyme, INC. | $14.66 | 2021 | |
| Astellas Pharma US INC | $13.93 | 2019 | |
| Karyopharm Therapeutics INC. | $13.36 | 2020 | |
| Seagen INC. | $12.83 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cinderella Radu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.